Prednisolon Alternova 5 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

prednisolon alternova 5 mg

alternova - prednisolon - tablett - 5 mg

Prednisolon Alternova 20 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

prednisolon alternova 20 mg

alternova - prednisolon - tablett - 20 mg

Dynastat 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

dynastat

pfizer europe ma eeig - parecoxibnatrium - smerte, postoperativ - coxibs, antiinflammatory and antirheumatic products - for kortsiktig behandling av postoperativ smerte hos voksne.

Eucreas 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

eucreas

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - eucreas is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control.

Icandra (previously Vildagliptin / metformin hydrochloride Novartis) 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

icandra (previously vildagliptin / metformin hydrochloride novartis)

novartis europharm limited - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes, combinations of oral blood glucose lowering drugs - icandra is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate glycaemic control (see sections 4. 4, 4. 5 og 5. 1 for tilgjengelige data på forskjellige kombinasjoner).

Zomarist 유럽 연합 - 노르웨이어 - EMA (European Medicines Agency)

zomarist

novartis europharm limited  - vildagliptin, metformin hydrochloride - diabetes mellitus, type 2 - legemidler som brukes i diabetes - zomarist is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus:in patients who are inadequately controlled with metformin hydrochloride alone. in patients who are already being treated with the combination of vildagliptin and metformin hydrochloride, as separate tablets. in combination with other medicinal products for the treatment of diabetes, including insulin, when these do not provide adequate.

Delmosart 18 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

delmosart 18 mg

teva b.v. - metylfenidathydroklorid - depottablett - 18 mg

Delmosart 27 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

delmosart 27 mg

teva b.v. - metylfenidathydroklorid - depottablett - 27 mg

Delmosart 36 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

delmosart 36 mg

teva b.v. - metylfenidathydroklorid - depottablett - 36 mg

Delmosart 54 mg 노르웨이 - 노르웨이어 - Statens legemiddelverk

delmosart 54 mg

teva b.v. - metylfenidathydroklorid - depottablett - 54 mg